Biocompatible polymeric nanoparticles are obtained via thiol‐ene polymerization of a biobased monomer in miniemulsion. The α,ω‐diene‐diester monomer is synthesized through esterification reaction of a glycerol derivative, namely 1,3‐propanediol, with 10‐undecenoic acid, a long‐chain diene carboxylic acid. In order to investigate how different monomeric structures behave toward thiol‐ene polymerization in miniemulsion, two types of thiols are investigated: 1,4‐butanedithiol and 2‐mercaptoethyl ether. Poly(thioether‐ester)s with weight average molecular weight up to 15 kDa (Mn) are obtained, depending on initiator concentration and types of surfactant and dithiol employed. Finally, biobased poly(thioether‐ester) nanoparticles are submitted to cytotoxicity and hemolysis analyses. High cell viability and no significant changes in cell morphology are observed after the incubation on murine fibroblast (L929) and human cervical cancer cells (HeLa). Last, hemolysis assays revealed blood compatibility and therefore polymeric nanoparticles have been shown to be a potential alternative drug delivery vector for intravenous administration.Practical Applications: There is a great demand for polymeric systems that fulfill a number of requirements, such as biodegradability and biocompatibility, for biomedical applications. In this context, biobased polymers obtained from vegetable oils are a very attractive sustainable alternative to fossil‐derived polymeric materials, presenting potential biodegradability and low toxicity. By thiol‐ene reactions, polymeric materials containing ester groups in the main chain—which can undergo hydrolysis—can be prepared in miniemulsion, enabling their degradation in physiological environment and, therefore, being interesting for biomedical applications and material disposal. Such novel materials could be used in temporary implants, tissue engineering, and drug delivery systems.Biocompatible polymeric nanoparticles are obtained via thiol‐ene polymerization of a biobased monomer in miniemulsion. Nanoparticles revealed to be a potential alternative controlled release drug delivery vector for intravenous administration.
Magnetic nanoparticles encapsulated in biocompatible and biodegradable polymeric matrices are promising materials for biomedical applications, such as transport of antitumoral drugs and cancer treatment by hyperthermia. In this study, biobased poly(thioether-ester), PTEe, was obtained by thiol-ene polymerization and superparamagnetic nanoparticles, MNPs, were successfully incorporated in PTEe nanoparticles by miniemulsification followed by solvent evaporation. MNPs-PTEe nanoparticles with average diameter around 150 nm presented superparamagnetic behavior as confirmed by magnetization curves analysis. MNPs-PTEe nanoparticles did not present hemolytic damage on human red blood cells when incubated for 24h. According to the cell viability assays, nanoparticles did not present any cytotoxic effect on murine fibroblast cell (NIH3T3) and human cervical cancer (HeLa). Hyperthermia assays were applied, demonstrating that AC magnetic field application (110 KHz – 500 Oe) for 20 min significantly reduced the cells viability. The morphology evaluation of HeLa showed a hypoxia region one hour after hyperthermia application . Therefore, the results indicated that the superparamagnetic poly(thioether-ester) nanoparticles can be an excellent alternative for the targeted delivery of antitumor drugs and cancer treatment for hyperthermia.
1 December 2014 in European Journal of Lipid Science and Technology